These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 10618553)
21. Induction of specific CD8+ memory T cells and long lasting protection following immunization with Salmonella typhimurium expressing a lymphocytic choriomeningitis MHC class I-restricted epitope. Shams H; Poblete F; Rüssmann H; Galán JE; Donis RO Vaccine; 2001 Nov; 20(3-4):577-85. PubMed ID: 11672924 [TBL] [Abstract][Full Text] [Related]
22. Mucosal priming of simian immunodeficiency virus-specific cytotoxic T-lymphocyte responses in rhesus macaques by the Salmonella type III secretion antigen delivery system. Evans DT; Chen LM; Gillis J; Lin KC; Harty B; Mazzara GP; Donis RO; Mansfield KG; Lifson JD; Desrosiers RC; Galán JE; Johnson RP J Virol; 2003 Feb; 77(4):2400-9. PubMed ID: 12551977 [TBL] [Abstract][Full Text] [Related]
23. Selection of the same major T cell determinants of influenza nucleoprotein after vaccination or exposure to infectious virus. Brett SJ; Gao XM; Liew FY; Tite JP J Immunol; 1991 Sep; 147(5):1647-52. PubMed ID: 1715366 [TBL] [Abstract][Full Text] [Related]
24. VaxCelerate II: rapid development of a self-assembling vaccine for Lassa fever. Leblanc P; Moise L; Luza C; Chantaralawan K; Lezeau L; Yuan J; Field M; Richer D; Boyle C; Martin WD; Fishman JB; Berg EA; Baker D; Zeigler B; Mais DE; Taylor W; Coleman R; Warren HS; Gelfand JA; De Groot AS; Brauns T; Poznansky MC Hum Vaccin Immunother; 2014; 10(10):3022-38. PubMed ID: 25483693 [TBL] [Abstract][Full Text] [Related]
25. Delivery of epitopes by the Salmonella type III secretion system for vaccine development. Rüssmann H; Shams H; Poblete F; Fu Y; Galán JE; Donis RO Science; 1998 Jul; 281(5376):565-8. PubMed ID: 9677200 [TBL] [Abstract][Full Text] [Related]
26. Lassa Virus Vaccine Candidate ML29 Generates Truncated Viral RNAs Which Contribute to Interfering Activity and Attenuation. Johnson DM; Cubitt B; Pfeffer TL; de la Torre JC; Lukashevich IS Viruses; 2021 Jan; 13(2):. PubMed ID: 33573250 [TBL] [Abstract][Full Text] [Related]
27. Development of live-attenuated arenavirus vaccines based on codon deoptimization. Cheng BY; Ortiz-Riaño E; Nogales A; de la Torre JC; Martínez-Sobrido L J Virol; 2015 Apr; 89(7):3523-33. PubMed ID: 25589652 [TBL] [Abstract][Full Text] [Related]
29. Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector. Juillard V; Villefroy P; Godfrin D; Pavirani A; Venet A; Guillet JG Eur J Immunol; 1995 Dec; 25(12):3467-73. PubMed ID: 8566039 [TBL] [Abstract][Full Text] [Related]
30. [Immunogenicity of S1 gene DNA vaccine of mouse hepatitis virus delivered by attenuated Salmonella typhimurium]. Jiao HM; Jiao XA; Yin YL; Pan ZM; Meng SS; Wang Y; Jiang JJ Wei Sheng Wu Xue Bao; 2007 Feb; 47(1):131-5. PubMed ID: 17436639 [TBL] [Abstract][Full Text] [Related]
31. Epitope mapping of the Lassa virus nucleoprotein using monoclonal anti-nucleocapsid antibodies. Hufert FT; Lüdke W; Schmitz H Arch Virol; 1989; 106(3-4):201-12. PubMed ID: 2476109 [TBL] [Abstract][Full Text] [Related]
32. Simultaneous expression of the Lassa virus N and GPC genes from a single recombinant vaccinia virus. Morrison HG; Goldsmith CS; Regnery HL; Auperin DD Virus Res; 1991 Mar; 18(2-3):231-41. PubMed ID: 2042398 [TBL] [Abstract][Full Text] [Related]
33. Lysis of infected cells in vivo by antiviral cytolytic T cells demonstrated by release of cell internal viral proteins. Kyburz D; Speiser DE; Battegay M; Hengartner H; Zinkernagel RM Eur J Immunol; 1993 Jul; 23(7):1540-5. PubMed ID: 8325330 [TBL] [Abstract][Full Text] [Related]
34. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety. II. Expression in avirulent Salmonella spp. for mucosal immunization. Schödel F; Kelly S; Tinge S; Hopkins S; Peterson D; Milich D; Curtiss R Adv Exp Med Biol; 1996; 397():15-21. PubMed ID: 8718577 [TBL] [Abstract][Full Text] [Related]
35. [The localization and preliminary characteristics of antigenic sites (B epitopes) in the nucleocapsid protein of the Lassa virus]. Vladyko AS; Bystrova SI; Malakhova IV; Kunitskaia LIa; Lemeshko NN; Kras'ko AG; Kozhich AT; Lukashevich IS Vopr Virusol; 1993; 38(1):30-4. PubMed ID: 7521097 [TBL] [Abstract][Full Text] [Related]
36. Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice. Berglund P; Fleeton MN; Smerdou C; Liljeström P Vaccine; 1999 Feb; 17(5):497-507. PubMed ID: 10073729 [TBL] [Abstract][Full Text] [Related]
37. Construction and Immunological Evaluation of an Adenoviral Vector-Based Vaccine Candidate for Lassa Fever. Wang M; Li R; Li Y; Yu C; Chi X; Wu S; Liu S; Xu J; Chen W Viruses; 2021 Mar; 13(3):. PubMed ID: 33804206 [TBL] [Abstract][Full Text] [Related]
38. Prime-boost immunization with DNA vaccine: mucosal route of administration changes the rules. Eo SK; Gierynska M; Kamar AA; Rouse BT J Immunol; 2001 May; 166(9):5473-9. PubMed ID: 11313385 [TBL] [Abstract][Full Text] [Related]
39. Envelope exchange for the generation of live-attenuated arenavirus vaccines. Bergthaler A; Gerber NU; Merkler D; Horvath E; de la Torre JC; Pinschewer DD PLoS Pathog; 2006 Jun; 2(6):e51. PubMed ID: 16751848 [TBL] [Abstract][Full Text] [Related]